2020
BioCentury: Algenex raises €7.4 million C round
15/09/2020Algenex’s latest financing will allow the Spanish biotech to ramp up its Baculovirus manufacturing technology, which could provide a cheaper and... Read More
Algenex will manufacture anticovid vaccines with chrysalis
01/09/2020Read complete article here: http://rsocial.elmundo.orbyt.es/epaper/xml_epaper/El%20Mundo/23_08_2020/pla_25589_Madrid/xml_arts/art_43976145.xml?SHARE=6C23C0F29C6C4F158F7CA6264B486305A825DAB9EDC5CC4E64BAD1EE05FFB08FC565BBFB1370B49326DF37CEB36526063192076CBE185CA3B79428930A4E694135DEEF0D2E0B73867BCA292A0BB37E337A0A5BF450AF7E63832D365985AC4F81 Read More
Viralgen obtains €30 million for the new manufacturing plant
29/07/2020July 2020, San Sebastián - Viralgen Vector Core, chosen to "mass" manufacture the COVID-19 vaccine, which is being developed by Massachusetts... Read More
Sanifit will start a new clinical development program of SNF472
23/07/2020Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease FDA has... Read More
Highlight announces first patient dosed in Phase IIa study in liver metastasis
26/06/2020Madrid, Spain -June 26, 2020: Highlight Therapeutics announces the dosing of the first patient in a Phase IIa clinical evaluation of... Read More
Artax Biopharma announces the Scientific Advisory Board for AX-158
24/06/2020Cambridge, Mass., June 24, 2020-Artax Biopharma, Inc., a biotechnology company focused on transforming autoimmune disease treatment, today announces the formation of... Read More
Artax: Series B Financing Extension for First-in-Class Autoimmune Disease Therapy
04/06/2020Cambridge, MA, June 4, 2020 - Artax Biopharma, Inc., a biotechnology company focused on transforming autoimmune disease treatment, today announces the... Read More
Sanifit Enhances Leadership Team with New Executive Appointments
03/06/2020Palma, Spain and San Diego, USA, 01 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification... Read More
Vivet’s Product, VTX-803, receives US and EU Orphan Drug Designation
01/06/2020PARIS, France June 1st, 2020, Vivet Therapeutics announced today that both the Food and Drug Administration (FDA) and the European Commission... Read More
Viralgen will produce the COVID-19 vaccine developed in USA
29/05/2020AAVCOVID Vaccine Program Expands Manufacturing Agreements with Gene Therapy Industry Partners Viralgen, Aldevron, and Catalent The AAVCOVID vaccine program at Massachusetts... Read More